Navigation Links
Dr. John Mills and Joseph Gentile Join Board of Directors of ChanTest Corporation
Date:11/11/2009

CLEVELAND, Nov. 11 /PRNewswire/ -- ChanTest, a leading provider of cardiac safety, ion channel, and GPCR services and products for drug discovery and development, today announced that Dr. F. John Mills and Joseph Gentile have been appointed to its board of directors. Dr. Mills is presently the CEO of BioStorage Technologies, Inc., which provides management, logistics, and biological specimens and data storage services for life sciences companies. Mr. Gentile is the former Vice President and General Manager of BD Biosciences Discovery Labware, where he helped to transform the business from a commodity lab plasticware supplier to a valued partner of researchers in life science and drug discovery.

"John and Joe bring a tremendous amount of global business strategy, management, and governance expertise to ChanTest," said Dr. Arthur (Buzz) Brown, President and CEO of ChanTest. "Both individuals have been responsible for helping to re-focus businesses to accelerate growth and add value for customers and key business stakeholders - valuable perspectives that they will bring to our Board. I look forward to working closely with them to help position ChanTest for even greater success."

Dr. Mills co-founded BioStorage Technologies in 2003, which currently serves over 100 life science companies worldwide. Dr. Mills previously held roles of increasing responsibility at Covance since 1991, most recently as the Corporate Senior Vice President and President, Clinical Support Services. In addition to Covance, he has held senior management positions at Corning and Janssen Pharmaceutical. Dr. Mills received his medical degree at Cambridge University, Pembroke College, a Ph.D. from the University of Surrey, and a Diploma in Pharmaceutical Medicine from the Royal College of Physicians, Edinburgh.

Mr. Gentile joined BD Biosciences in 1996, where he served in several senior management positions of increasing responsibility. Prior to BD, Mr. Gentile also held management responsibilities at Hewlett-Packard, and engineering roles at AVCO Everett Research Lab, ELSCINT, Inc. and Advanced NMR Systems. Mr. Gentile holds a bachelor's degree in electrical engineering from Northeastern University, a master's degree in electrical engineering and an M.B.A. from Boston University, and has completed executive education programs at Harvard University and the Massachusetts Institute of Technology. He is a Director of the New England Healthcare Institute, and serves as an Advisory Board member for Vertify, Inc.

About ChanTest Corporation (www.chantest.com)

ChanTest's mission is to serve the research, drug discovery and drug development needs of customers worldwide with high-value solutions for ion channel and GPCR biology. ChanTest offers integrated ion channel and GPCR services (GLP and non-GLP), cell lines, membranes and reagents; the company's library of validated ion channel cell lines is the most comprehensive, commercially available offering today. ChanTest's pre-clinical cardiac risk assessment service portfolio is the most complete offering of its kind. Since its inception in 1998, the company has tested compounds for more than 500 global pharmaceutical and biotechnology companies. ChanTest works in partnership with customers to speed the drug development process, and ultimately to help make better, safer drugs. Because of ChanTest's seminal role in the pre-clinical cardiac safety field, along with the company's uncompromising commitment to quality, ChanTest has been named the "most trusted and most used fee-for-service provider" for ion channel screening in an independent survey for the past three years. ChanTest is based in Cleveland, Ohio. For more information, e-mail info@chantest.com.

SOURCE ChanTest Corporation


'/>"/>
SOURCE ChanTest Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion
2. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
3. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
4. American Board of Internal Medicine President Named to Alzheimers Study Group
5. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
6. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
7. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
8. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
9. UBC Forms European Advisory Board to Enhance Data Quality of CNS Trials
10. ASPIRE Independent Review Board Announces 10 Ways to Protect Participants Rights in Clinical Drug Trials and Optimize Results From Research
11. Silence Therapeutics Announces Board Changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... December 2, 2016 According ... Diagnostics/IVD Market by Product (Instruments, Reagents, Software), Technology ... Oncology, Cardiology, Nephrology, Infectious Diseases) - Forecast to ... valued at USD 60.22 Billion in 2016. This ... of 5.5% during the forecast period (2016-2021) to ...
(Date:12/2/2016)... 2, 2016  The Addiction Treatment Advisory Group ... Managed Care Pharmacy (AMCP), has released detailed findings ... the opioid addiction crisis, including through improved access ... ATAG,s newly released paper, "The Role of ... addresses many issues around gaps and barriers to ...
(Date:12/2/2016)... , Dec. 2, 2016 Boston Scientific ... definitive agreement to acquire certain manufacturing assets and capabilities ... (TSX: NVC) advanced biological tissue business, as well as ... of $75 million in cash. The Neovasc advanced biological ... including the Boston Scientific Lotus™ Valve System. * ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... 2016 , ... More than 100 business, civic, community and ... the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. 9, 2016. This inaugural event, hosted by ... support to UNCF-member institutions, including Miles College, Oakwood University, Tuskegee University, Stillman College ...
(Date:12/2/2016)... ... December 02, 2016 , ... U.S. Surgeon General, Dr. Vivek Murthy, graces the ... how he was inspired to practice medicine at an early age by his father, ... than making diagnoses and prescribing medicine,” he states. “It is about building relationships with ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet is proud to ... which covers the innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping ... prolonging life 6 years in the last 3 decades,” says Dr. Valentine Fuster, ...
(Date:12/2/2016)... ... 02, 2016 , ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique ... other wearable health technology on the market can deliver all that rejiva can. , ... insights about their health than the usual heart rate and steps taken”, adds Evens ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... organizations to build intelligent, connected applications, was named the best Sales Team of ... The winner announcement was made today by the Software & Information Industry Association ...
Breaking Medicine News(10 mins):